An invisible bleed can often be minimized because it doesn't match the classic image of bleeding disorders, says columnist Jennifer Lynne.

Many women who are hemophilia carriers remain undiagnosed and lack access to care, a multinational study reports.

Columnist Joe MacDonald considers how each of his sons define freedom given their experiences with hemophilia complications ...

What we do and say matters, particularly in the lives of children with an invisible illness, writes columnist Allyx Formalejo ...

Bemiltenase alfa, an FX activator, helped with on-demand bleeding control in early trials with hemophilia A and B patients ...

After a procedure for SMAS, columnist G Shellye Horowitz is dealing with hair loss and restless leg, results of low iron and ...

I knew back flips and aerial twirls weren’t in my reach, so I set my sights on mastering the cartwheel. But it was never to happen. Trusting my outstretched hand to send my body and feet over to the ...

Columnist Joe MacDonald worries about his son's treatment compliance, but watching Caeleb thrive makes him feel like a proud dad.

Biomarin Pharmaceutical is looking to sell off rights to Roctavian (valoctocogene roxaparvovec-rvox), its approved gene therapy for hemophilia A. “As we focus on the business units aligned with our ...

Hemophilia is a blood disorder that is characterized by a shortage of specific clotting factors that help to form blood clots and stop bleeding. Historically, the primary treatment for hemophilia is ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Many women with hemophilia are undiagnosed due to systemic ...

Centessa Pharmaceuticals is discontinuing the clinical development of SerpinPC, its experimental under-the-skin therapy for people with hemophilia A and hemophilia B with or without inhibitors. The ...